Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.00027 | 1 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-10 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.22 | 8e-09 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-08 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-08 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-08 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |